Back to IEQ CAPITAL, LLC

NBIX
Showing 8 of 12 quarters

Position history for IEQ CAPITAL, LLC's holdings in NEUROCRINE BIOSCIENCES INC

IEQ CAPITAL, LLC holds 765,982 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $100.9M as of 2026-Q1. The position was increased (+2.8% shares). NBIX represents 0.5% of IEQ CAPITAL, LLC's portfolio.

Current Value

$100.9M

Current Shares

765,982

Total Value Change

+$31.2M

Total Shares Change

+259,896

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
765,982
+2.8%
$100.9M0.5%$131.14
37
2025-Q4
Increased
745,113
+7.6%
$105.7M0.3%$140.95
39
2025-Q3
Increased
692,601
+20.9%
$97.2M0.3%$140.27
43
2025-Q2
Increased
572,973
+6.7%
$72M0.4%$125.42
38
2025-Q1
Decreased
537,017
-3.7%
$59.4M0.5%$113.16
0
2024-Q4
Increased
557,904
+8.9%
$76.2M0.7%$137.06
46
2024-Q3
Increased
512,480
+1.3%
$59M0.7%$115.06
42
2024-Q2
Decreased
506,086
-0.0%
$69.7M0.9%$137.67
0

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used